WENYE GROUP (01802): The Listing Committee has therefore decided to maintain the listing decision and suspend trading in the company's shares.
Wenye Group (01802) announced that the Listing Committee has made a decision to proceed with the listing of science on September 2, 2025.
WENYE GROUP (01802) announces that the Listing Committee has scheduled a review hearing on the listing decision for the Company on September 2, 2025. The Company received a letter from the Stock Exchange Listing Committee on September 23, 2025, informing that the Committee has reviewed the Company's situation and decided that the Company failed to maintain sufficient operating scale and assets of sufficient value to support its operations, thus not meeting the requirements of Rule 13.24 of the listing rules, and is therefore not suitable for listing. The Listing Committee has decided to uphold the listing decision and suspend the trading of the Company's shares in accordance with Rule 6.01(3) of the listing rules.
According to Chapter 2B of the listing rules, the Company has the right to request that the decision of the Listing Committee be referred to the Listing Review Committee for review. Any application for review must be submitted to the Secretary of the Listing Review Committee within seven business days of the date of the Listing Committee's decision (on or before October 3, 2025). Unless the Company applies for a review, trading of the Company's shares will be suspended seven business days after the Listing Committee's decision (on October 6, 2025).
The Company is reviewing the decision of the Listing Committee and is in discussions with internal and professional advisors to consider whether to request that the decision be referred to the Listing Review Committee for review.
Related Articles
.png)
HK Stock Market Move | YIDU TECH (02158) up more than 5%, wins bid for SMR001 Eye Drops Phase III Clinical Research Project.

HK Stock Market Move | SICC Co., Ltd. (02631) rose more than 4% in the morning, AR glasses are again attracting market attention, the company has obvious advantages in the silicon carbide AR glasses track.

UBS Group AG: Symbotic (SYM.US) is valued very high and has too concentrated customer base, rating lowered to "sell"
HK Stock Market Move | YIDU TECH (02158) up more than 5%, wins bid for SMR001 Eye Drops Phase III Clinical Research Project.
.png)
HK Stock Market Move | SICC Co., Ltd. (02631) rose more than 4% in the morning, AR glasses are again attracting market attention, the company has obvious advantages in the silicon carbide AR glasses track.

UBS Group AG: Symbotic (SYM.US) is valued very high and has too concentrated customer base, rating lowered to "sell"

RECOMMEND

Drivers and Momentum Across China, Hong Kong and U.S. Markets: Rotation, AI Linkages, and Valuation Dynamics
23/09/2025

Largest Outperformance in Eight Years as Asian Stocks Poised to Sustain Edge Over U.S. Equities
23/09/2025

Ministry of Industry and Information Technology Sets New Strategic Tracks for Emerging Future Industries
23/09/2025